Aum Biosciences

Aum Biosciences Sprim Global Investments Aum biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi faceted inhibition strategies to reverse cancer resistance. Aum biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi faceted inhibition strategies to reverse cancer resistance.

Aum Biosciences Linkedin Explore aum biosciences' in depth company profile, including funding details, key investors, leadership, and competitors. Information on valuation, funding, cap tables, investors, and executives for aum biosciences. use the pitchbook platform to explore the full profile. Aum biosciences is a biotechnology company involved in the development of oncology therapeutics. the company works on treatments that use inhibition strategies to address cancer resistance. With a well established healthcare system, world class research facilities, and a collaborative government, singapore has become an attractive place for biotech companies like aum biosciences.

Aum Biosciences Ceo Vishal Doshi Participated In A Very Engaging Panel Aum biosciences is a biotechnology company involved in the development of oncology therapeutics. the company works on treatments that use inhibition strategies to address cancer resistance. With a well established healthcare system, world class research facilities, and a collaborative government, singapore has become an attractive place for biotech companies like aum biosciences. Aum biosciences is a global clinical stage biotech company that was founded in 2018. aum is focused on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. Examples include the license agreement that inflection biosciences signed with aum biosciences to conduct the development of ibl 302, also known as aum302, a first in class triple inhibitor of pan pim, pan pi3k and mtor kinases, presently in ind enabling trials for neuroblastoma and cancers with pi3kca mutations. Find company research, competitor information, contact details & financial data for aum biosciences pte. ltd. of singapore . get the latest business insights from dun & bradstreet. Through technological and engineering breakthroughs in biosciences and genetics, colossal is accepting humanity’s duty to restore earth to a healthier state, while also solving for the future economies and biological necessities of the human condition.

Aum Biosciences Linkedin Aum biosciences is a global clinical stage biotech company that was founded in 2018. aum is focused on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. Examples include the license agreement that inflection biosciences signed with aum biosciences to conduct the development of ibl 302, also known as aum302, a first in class triple inhibitor of pan pim, pan pi3k and mtor kinases, presently in ind enabling trials for neuroblastoma and cancers with pi3kca mutations. Find company research, competitor information, contact details & financial data for aum biosciences pte. ltd. of singapore . get the latest business insights from dun & bradstreet. Through technological and engineering breakthroughs in biosciences and genetics, colossal is accepting humanity’s duty to restore earth to a healthier state, while also solving for the future economies and biological necessities of the human condition.

Aum Bioscience Find company research, competitor information, contact details & financial data for aum biosciences pte. ltd. of singapore . get the latest business insights from dun & bradstreet. Through technological and engineering breakthroughs in biosciences and genetics, colossal is accepting humanity’s duty to restore earth to a healthier state, while also solving for the future economies and biological necessities of the human condition.

Aum Bioscience